{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:27:14Z","timestamp":1793618834684,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ymgmr.2026.101368","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:24:39Z","timestamp":1791030279000},"page":"101368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genetic testing to distinguish X-linked protoporphyria from erythropoietic protoporphyria informed iron replacement therapy leading to reversal of severe protoporphyric hepatopathy"],"prefix":"10.1016","volume":"49","author":[{"given":"Christopher D.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siob\u00e1n B.","family":"Keel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2026.101368_bb0005","article-title":"Recognized and emerging features of erythropoietic and X-linked protoporphyria","volume":"12","author":"Di Pierro","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymgme.2019.01.020","article-title":"Erythropoietic protoporphyria and X-linked protoporphyria: pathophysiology, genetics, clinical manifestations, and management","volume":"128","author":"Balwani","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0015","series-title":"GeneReviews((R)), Seattle (WA)","article-title":"X-linked protoporphyria","author":"Balwani","year":"1993"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2119\/molmed.2012.00340","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/HEP.0000000000000546","article-title":"Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protoporphyria","volume":"79","author":"Levy","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000657","article-title":"Liver involvement in a large cohort of patients with erythropoietic protoporphyria or X-linked protoporphyria","volume":"9","author":"Levy","year":"2025","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0035","first-page":"2921","article-title":"How I treat erythropoietic protoporphyria and X-linked protoporphyria","volume":"141","author":"Leaf","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15924","article-title":"Case-based discussion of the acute hepatic porphyrias: updates on pathogenesis, diagnosis and management","volume":"45","author":"Balwani","year":"2025","journal-title":"Liver Int."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0045","series-title":"GeneReviews((R)), Seattle (WA)","article-title":"Erythropoietic protoporphyria, autosomal recessive","author":"Balwani","year":"1993"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0050","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(89)92688-3","article-title":"Controlled trial of haem arginate in acute hepatic porphyria","volume":"1","author":"Herrick","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0055","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1111\/petr.12472","article-title":"Bone marrow transplant for X-linked protoporphyria with severe hepatic fibrosis","volume":"19","author":"Butler","year":"2015","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0060","doi-asserted-by":"crossref","first-page":"e1896","DOI":"10.1542\/peds.2006-0833","article-title":"Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria","volume":"118","author":"Rand","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2006.10.004","article-title":"Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis","volume":"46","author":"Wahlin","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.13612","article-title":"X-linked protoporphyria: Iron supplementation improves protoporphyrin overload, liver damage and anaemia","volume":"173","author":"Landefeld","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1509803","article-title":"Long-term iron supplementation in four patients with X-linked erythropoietic protoporphyria: associations with serum proteins and erythrocyte protoporphyrin levels-a single-centre retrospective study","volume":"12","author":"Minder","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0080","article-title":"A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria","volume":"33","author":"Balwani","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0085","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/lt.22341","article-title":"Liver transplantation for erythropoietic protoporphyria in Europe","volume":"17","author":"Wahlin","year":"2011","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0090","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/lt.20620","article-title":"Liver transplantation for erythropoietic protoporphyria liver disease","volume":"11","author":"McGuire","year":"2005","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, biochemical, and genetic characterization of North American patients with erythropoietic protoporphyria and X-linked protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0100","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0105","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1074\/jbc.M114.547778","article-title":"Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria","volume":"289","author":"Chung","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101643","article-title":"Structural basis for dysregulation of aminolevulinic acid synthase in human disease","volume":"298","author":"Taylor","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcmd.2014.07.017","article-title":"In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability","volume":"54","author":"Barman-Aksozen","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0120","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2009-09-243105","article-title":"Posttranslational stability of the heme biosynthetic enzyme ferrochelatase is dependent on iron availability and intact iron-sulfur cluster assembly machinery","volume":"115","author":"Crooks","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/hematology.2020000132","article-title":"Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick?","volume":"2020","author":"Fertrin","year":"2020","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0135","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/eci.12503","article-title":"Homeostasis of iron and hepcidin in erythropoietic protoporphyria","volume":"45","author":"Bossi","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0140","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1373\/clinchem.2015.245456","article-title":"Pitfalls in erythrocyte protoporphyrin measurement for diagnosis and monitoring of protoporphyrias","volume":"61","author":"Gou","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0145","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181875","article-title":"The GLYT1 inhibitor bitopertin mitigates erythroid PPIX production and liver disease in erythroid protoporphyria","volume":"135","author":"Ducamp","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0150","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.123.001582","article-title":"Roles of the ABCG2 transporter in protoporphyrin IX distribution and toxicity","volume":"52","author":"Qi","year":"2024","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6127","article-title":"The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria","volume":"5","author":"Wang","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/life13041066","article-title":"Afamelanotide is associated with dose-dependent protective effect from liver damage related to erythropoietic protoporphyria","volume":"13","author":"Minder","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0165","article-title":"Afamelanotide for treatment of the protoporphyrias: impact on quality of life and laboratory parameters in a US cohort","volume":"14","author":"Leaf","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ymgmr.2026.101368_bb0170","article-title":"Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study","volume":"2","author":"Minder","year":"2021","journal-title":"Ther. Adv. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0175","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJMoa2208754","article-title":"Dersimelagon in erythropoietic protoporphyrias","volume":"388","author":"Balwani","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2026.101368_bb0180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.molmed.2024.05.006","article-title":"Erythropoietic protoporphyrias: updates and advances","volume":"30","author":"Poli","year":"2024","journal-title":"Trends Mol. Med."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:49:28Z","timestamp":1793616568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426926000807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S2214426926000807"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101368","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing to distinguish X-linked protoporphyria from erythropoietic protoporphyria informed iron replacement therapy leading to reversal of severe protoporphyric hepatopathy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101368"}}